Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avidity Biosciences Inc (NQ: RNA )

27.45 -0.02 (-0.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 658,347
Open 27.66
Bid (Size) 27.00 (8)
Ask (Size) 28.20 (22)
Prev. Close 27.47
Today's Range 27.01 - 28.39
52wk Range 4.825 - 30.84
Shares Outstanding 54,462,518
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
Discover three top Nasdaq stocks to buy. Learn about these investment opportunities and why they’re worth your attention. 
Via InvestorPlace
RNA Stock Earnings: Avidity Biosciences Misses EPS, Beats Revenue for Q1 2024
RNA stock results show that Avidity Biosciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+199.67%
+199.67%
1 Month
+9.23%
+9.23%
3 Month
+88.79%
+88.79%
6 Month
+338.50%
+338.50%
1 Year
+142.71%
+142.71%

More News

Read More
Navigating 7 Analyst Ratings For Avidity Biosciences
Via Benzinga
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Via Benzinga
Topics ETFs
Where Avidity Biosciences Stands With Analysts
Via Benzinga
This Demand Zone In S&P 500 Needs To Hold
Via Talk Markets
Topics Stocks
Exposures US Equities
A Closer Look at 5 Analyst Recommendations For Avidity Biosciences
Via Benzinga
Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
Via Benzinga
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Avidity Biosciences Says Lead Program Shows Reversal Of Disease Progression In Neuromuscular Disease
Via Benzinga
Top 2% Biotech Avidity Collapses Despite 'Positive' Results In Treating Muscular Dystrophy
Via Investor's Business Daily
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Top 3 Health Care Stocks You May Want To Dump In Q1
Via Benzinga
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
3 Highly Rated Biotech Stocks to Buy for 300% Gains
Via InvestorPlace
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
FCEL Stock Alert: FuelCell Energy Announces AI Deal With IBM
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Lion Electric Layoffs 2023: What to Know About the Latest LEV Job Cuts
Via InvestorPlace
Topics Electric Vehicles Workforce
Exposures Electric Vehicles Layoff
Why Is Avidity Biosciences (RNA) Stock Up 15% Today?
Via InvestorPlace
PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.